Figure 10.
In vivo anticancer efficacy evaluation. (A) Body weights of mice after different treatments. (B) Cancer growth curves of different groups of cancer-bearing mice after various treatments indicated for 12 days. (C) Pictures of the harvested cancers. (D) Cancer weight of different groups. *p< .01 vs. PBS; #p< .05 vs. EMS or PBS. Data were presented as mean ± SD, n = 8. (E) H&E, TUNEL, and Ki-67 staining in cancer sections collected from differently treated groups of mice. ‘↗’ represents cancer cells apoptosis and proliferation, respectively.
